Pre-clinical models in brain cancer
Dr Mark Gilbert - National Cancer Institute, Bethesda, USA
11 May 2018
Passage of treatments at the blood-brain barrier
Prof William Elmquist - University of Minnesota, Minneapolis, USA
11 May 2018
Diagnostics and classification of brain tumours
Dr David Louis - Massachusetts General Hospital, Boston, USA
11 May 2018
Personalised approaches to paediatric ependymoma
Dr Stephen Mack - Baylor College of Medicine, Houston, USA
11 May 2018
Identifying drivers of resistance in childhood brain tumours
Dr Pratiti Bandopadhayay - Dana-Farber Cancer Institute, Boston, USA
11 May 2018
Single cell genomic technologies in brain tumours
Dr Mario Suvà - Massachusetts General Hospital, Boston, USA
11 May 2018
Cancer Research UK Brain Tumour Conference
Dr Johanna Joyce - Ludwig Institute for Cancer Research and the University of La...
11 May 2018
Lessons from mouse models of glioblastoma
Dr Luis Parada - Memorial Sloan Kettering Cancer Center, New York, USA
11 May 2018
Funding collaborations and discovery in treating brain cancers
Dr Iain Foulkes - Executive Director, Research & Innovation / CEO of Cancer Rese...
11 May 2018
Incorporating biomarkers into clinical trial design
Dr Amar Gajjar - St. Jude Children's Research Hospital, Memphis, USA
11 May 2018
Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy
Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA
25 Apr 2018
Editor's Choice for February 2018
Prof Gordon McVie - Founding Editor, ecancer
26 Feb 2018
